7
Participants
Start Date
January 10, 2018
Primary Completion Date
January 10, 2019
Study Completion Date
June 10, 2019
PEGylated Recombinant Human Hyaluronidase (PEGPH20)
PEGPH20 will be administered at a dose of 3.0 micrograms per kilogram (μg/kg) as an intravenous (IV) infusion.
Avelumab
Avelumab will be administered as at a dose of 10 milligrams per kilogram (mg/kg) as an intravenous (IV) infusion once every 2 weeks.
Hospital Universitario La Paz, Madrid
Hospital Universitario Fuenlabrada, Fuenlabrada
Hospital Ramon y Cajal, Madrid
Lead Sponsor
PH Research, S.L.
OTHER